Plasma thrombomodulin: A marker for microvascular complications in diabetes mellitus

Vasa - Journal of Vascular Diseases

Volumn 25, Issue 3, 1996, Pages 233-241

  Gabat, S ^a   Keller, C ^a   Kempe, H P ^a   Amiral, J ^b   Ziegler, R ^a   Ritz, E ^a   Bergis, K H ^c   Wahl, P ^a   Nawroth, P ^a,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Forsch Inst der Diabetes Akademie   (Germany)

^c Serbio   (France)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; ENDOTHELIN 1; OXYGEN RADICAL; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HEART HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MICROVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; VASCULITIS;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; THROMBOMODULIN;

EID: 0029787382     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. AMIRAL J, ADAM M, MIMILLA F, LARRIVAZ I, PLASSART V, GROSLEY M. Measurement of soluble forms of thrombomodulin in plasma; «Haemostasis and Cancer», Mulhouse October 19-20, 1990.
2. BÖHME MWJ, V. RIEDESEL J, NAWROTH PP, KLING E, LIN J, AMIRAL J, RÄTH U, SCHERBAUM WA. Serum thrombomodulin - a novel marker of disease activity in systemic lupus erythematosus. Arth and Rheumatism 1994; 37: 572-7.
3. BORCH-JOHNSEN K, KREINER S. Proteinuria as a predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 1987; 294: 1651-4.
4. BROWNLEE M, CERAMI A, VLASSARA H. Advanced glycosylation endproducts in tissue and the biochemical basis of diabetic complications. N Eng J Med 1988; 318: 1315-20.
5. DAMSGAARD EM, FROLAND A, JORGENSEN OD, MOGENSEN CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300:297-300.
6. DECKERT T, FELDT-RASMUSSEN B, BORCH-JOHNSEN K, JENSEN T, KOFOLD-ENEVOLDSEN A. Albuminuria reflects widespread vascular damage. The steno hypothesis. Diabetologia 1988; 32: 219-26.
7. DITTMAN WA, MAJERUS PW. Structure and function of thrombomodulin: a natural anticoagulant. Blood 1990; 75 (2): 329-36.
8. ESMON CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348-52.
9. ESMON NC. Thrombomodulin. Sem in Thromb Hemost 1987; 13: 454-63.
10. ESPOSITO C, GERLACH H, BRETT J, STERN D, VLASSARA H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 1989; 170: 1387-1407.
11. GRUDEN G, GAVALLO-PERIN P, BAZZAN M, STELLA S, VUOLO A, PAGANO G. PAI-1 and factor VIII activity are higher in IDDM patients with microalbuminuria. Diabetes 1994; 43: 426-9.
12. HAMADA H, ISHII H, SAKYO K, HORIE S, NISHKI K, KAZAMA M. The epidermal growth factor-like domain of recombinant human thrombomodulin exhibits mitogenic activity for swiss 3T3 cells. Blood 1995; 86 (1): 225-33.
13. HEMMER CJ, BIERHAUS A, V. RIEDESEL J, GABAT S, LILIENSIEK B, PITRONIK P, LIN J, AMIRAL J, ZIEGLER R, SCHIEFFER S, KERN P, SEITZ R, EGBRING R, DIETRICH M, NAWROTH PP. Elevated thrombomodulin plasma levels as a result of endothelial involvement in p. falciparum malaria. Thromb Haemost 1994; 72 (3): 457-56.
14. HEMMER CJ, KERN P, HOLST FGE, RADTKE KP, EGBRING FG, BIERHAUS A, NAWROTH PP, DIETRICH M. Activation at the host response in human plasmodium falciparum malaria: relation of parasitemia of tumor necrosis factor/ cachectin, thrombin-antithrombin III and protein C levels. Am J Med 1991; 91: 37-44.
15. HERGESELL O, ANDRASSY K, GEBERTH S, NAWROTH P, GABAT S. Plasma thrombomodulin levels are dependent on renal function. Thromb Res 1993; 72: 455-8.
16. ISHII H, MAJERUS PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985; 76: 2178-81.
17. ISHII H, NAKANO M, TSUBOUCHI J, ISHIKAWA T, UCHIYAMA H, HIRAISHI S, TAKARA C, MIYAJIMA Y, KAZAMA M. Establishment of enzyme immune assay of human thrombomodulin in plasma and urine using monoclonal antibodies. Thromb Haemost 1990; 63 (2): 157-62.
18. ISHII H, UCHIYAMA H, KAZAMA M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991; 65 (5): 618-23.
19. IWASHIMA Y, SATO T, WATANABE K, OOSHIMA E, HIRAISHI S, ISHII H, KAZAMA M, MAKINO I. Elevation of plasma thrombomodulin levels in diabetic patients with early diabetic nephropathy. Diabetes 1990; 39: 983-7.
20. JUHAN-VAGUE I, ROUL C, ALESSI MC, ARDISSONE JP, HEIM M, VAGUE P. Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients - relationship with plasma insulin. Thromb Haemost 1989; 61 (3): 370-3.
21. KIRSTEIN M, BRETT J, RADOFF S, OGAWA S, STERN D, VLASSARA H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc. Natl. Acad. Sci. USA 1990; 87: 9010-4.
22. LARKINS RG, DUNLOP ME. The link between hyperglycemia and diabetic nephropathy. Diabetologia 1992; 35: 499-504.
23. LEWIS J, HUNSICKER L, BAIN R, RHODE R. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Eng J Med 1993; 329 (20): 1456-62.
24. LORENZI M, CAGLIERO E. Pathobiology of endothelial and other vascular cells in diabetes mellitus. Diabetes 1991; 40: 653-9.
25. MARUYAMA I, BELL CE, MAJERUS PW. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics and on human syncytiotrophoblast of human placenta. J Cell Biol 1985; 101: 263-71.
26. MOGENSEN CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Eng J Med 1984; 310: 356-60.
27. MORGENSEN CE, CHRISTIANSEN CK. Predicting diabetic nephropathy in insulin-dependent patients. N Eng J Med 1984; 311: 83-93.
28. NAWROTH PP, WALDHERR R, ZHANG YM, LIN J, BIERHAUS A, LU J, V. RIEDESEL J, ZU EJ, KASPERK C, ZIEGLER R. Mechanisms of endothelial cell activation. Transpl Proceedings 1993; 25 (2): 2052-3.
29. NEEPER M, SCHMIDT AM, BRETT J, YAN SD, WANG F, PAN YC, ELLISTON K, STERN D, SHAW A. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation endproducts of proteins. J Biol Chem 1992; 267: 14998-15004.
30. NORDT TK, KLASSEN KJ, SCHNEIDER DJ, SOBEL BE. Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis. Arterioscl Thromb 1993; 13 (12): 1822-7.
31. PARVING HH, OXENBOLL B, SVENDSEN PA, CHRISTIANSEN JS, ANDERSON AR. Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of albumin excretion. Acta Endocrinol 1982; 100: 550-5.
32. PEDRINELLI R, DI BELLO V, CATAPANO G, TALARICO L, MATERAZZI F, SANTORO G, GIUSTI C, MOSCA F, MELILLO E, FERRARI M. Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinaemia in nondiabetic atherosclerotic patients. Arteriosclerosis and Thrombosis 1993; 13 (6): 900-6.
33. PORTA M, LA SELVA M, MOLINATTI P, MOLINATTI GM. Endothelial cell function in diabetic microangiopathy. Diabetologia 1987; 30: 601-9.
34. ROMERO R, SALINAS I, LUCAS A, ABAD E, REVERTER J, JOHNSTON S, SANMARTI A. Renal function changes in microalbuminuric normotensive type II diabetic patients treated with ACE-inhibitors. Diabetes Care 1993; 16 (4): 597-600.
35. SCHMIDT AM, YAN SD, BRETT J, MORA R, NOWYGROD R, STERN D. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 1993; 92: 2155-68.
36. SERNAU T, WILHELM C, SEYFERT U, GABAT S, HENKELS M, AMIRAL J, BEROIS KH, ZIEGLER R, WAHL P, NAWROTH PP. Thrombomodulin is a marker for microvascular but not for macrovascular endothelial cell damage. VASA 1995; 24: 347-53.
37. SIDO B, DATSIS C, MERHABI A, KRAUS T, KLAR T, OTTO G, HERFARTH C, NAWROTH PP. Soluble thrombomodulin, an endothelial cell marker of reperfusion injury after orthoptic liver transplantation. Transplantation: in press, 1995.
38. STEHOUWER CDA, STROES ESG, HACKENG WHL, MULDER PGH, DEN OTTOLANDER GJH. Von Willebrand Factor and development of diabetic nephropathy in IDDM. Diabetes 1991; 40: 971-6.
39. STEHOUWER CDA, ZELLENRATH P, POLAK BCP, BAARSMA GS, NAUTA JJP, DONKER, AJM, DEN OTTOLANDER GJH. Von Willebrand Factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion. Diabetologia 1992; 35: 555-9.
40. TAKANO S, KIMURA S, OHDAMA S, AOKI N. Plasma thrombomodulin in health and diseases. Blood 1990; 76 (10): 2024-9.
41. TANAKA A, ISHII H, HIRAISHI S, KAZAMA M, MAEZAWA H. Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clinical Chemistry 1991; 37 (2): 269-72.
42. THOMPSON EA, SALEM HH. Inhibition by human thrombomodulin of factor Xa-mediated cleavage of prothrombin. J Clin Invest 1986; 78: 13-7.
43. VANE JR, ANGGARD EE, BOTTING RM. Mechanisms of disease: regulatory functions of vascular endothelium. N Eng J Med 1990; 323: 27-36.
44. VIBERTI EC. Mechanisms of diabetic renal and caridovascular disease. Acta Diabetologica 1990; 27: 267-76.
45. WOLPERT HA, STEEN SN, ISTFAN NW, SIMONSON DC. Insulin modulates circulating endothelin-1 levels in humans. Metabolism 1993; 42: 1027-30.
46. YUDKIN JS, FORREST RD, JACKSON CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988: 2531-4.